Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Janux Therapeutics, Inc. (JANX) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$3.73M |
|
$-24.36M |
|
-- |
|
$3.73M |
|
$37.95M |
|
$-34.21M |
|
$9.85M |
|
$-24.36M |
|
$-24.36M |
|
$-24.36M |
|
$-24.36M |
|
$-24.36M |
|
$-24.36M |
|
$-34.21M |
|
$-36.37M |
|
62.67M |
|
62.67M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$1.00B |
|
$3.55M |
|
$26.18M |
|
$1.03B |
|
$58.91M |
|
-- |
|
$27.77M |
|
$86.69M |
|
$941.53M |
|
$941.53M |
|
$941.53M |
|
60.87M |
|
| Cash Flow Statement Financials | |
$-12.34M |
|
$8.29M |
|
$3.54M |
|
$53.15M |
|
$52.64M |
|
$-0.51M |
|
$9.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.01 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-916.50% |
|
-916.50% |
|
-- |
|
-652.59% |
|
-652.59% |
|
$-12.61M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.11 |
|
843.83 |
|
-2.59% |
|
-2.59% |
|
-2.37% |
|
-2.59% |
|
$15.47 |
|
$-0.20 |
|
$-0.20 |
|